NEW YORK (GenomeWeb News) – China's Ministry of Commerce has approved Thermo Fisher's $15.8 billion acquisition of Life Technologies, pending the divestiture of Thermo Fisher's cell culture business and several other conditions.

In addition to the sale of the cell culture business, the Ministry of Commerce has asked Thermo Fisher to sell its stake in Lanzhou National Hyclone Bio-engineering Co., to divest its gene modulation business, and to reduce the price of its SSP kits and SDS-PAGE protein standards in the Chinese market.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.

George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.

A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.

The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.